Warning: The NCBI web site requires JavaScript to function. more...
Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores.
Moore RA, Moore OA, Derry S, McQuay HJ.
Arthritis Res Ther. 2008;10(2):R39. Epub 2008 Apr 2.
Related citations
Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.
Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H.
Ann Rheum Dis. 2010 Feb;69(2):374-9. Epub 2009 Apr 12.
Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial.
Wiesenhutter CW, Boice JA, Ko A, Sheldon EA, Murphy FT, Wittmer BA, Aversano ML, Reicin AS; Protocol 071 Study Group.
Mayo Clin Proc. 2005 Apr;80(4):470-9.
A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis.
Puopolo A, Boice JA, Fidelholtz JL, Littlejohn TW, Miranda P, Berrocal A, Ko A, Cichanowitz N, Reicin AS.
Osteoarthritis Cartilage. 2007 Dec;15(12):1348-56. Epub 2007 Jul 16.
Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis.
Bingham CO 3rd, Bird SR, Smugar SS, Xu X, Tershakovec AM.
Osteoarthritis Cartilage. 2008 Nov;16(11):1289-93. Epub 2008 Jun 2.
Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
Gottesdiener K, Schnitzer T, Fisher C, Bockow B, Markenson J, Ko A, DeTora L, Curtis S, Geissler L, Gertz BJ; Protocol 007 Study Group.
Rheumatology (Oxford). 2002 Sep;41(9):1052-61. Erratum in: Rheumatology (Oxford). 2003 Jun;42(6):814.
Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489].
Curtis SP, Bockow B, Fisher C, Olaleye J, Compton A, Ko AT, Reicin AS.
BMC Musculoskelet Disord. 2005 Dec 1;6:58.
Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.
Birbara CA, Puopolo AD, Munoz DR, Sheldon EA, Mangione A, Bohidar NR, Geba GP; Etoricoxib Protocol 042 Study Group.
J Pain. 2003 Aug;4(6):307-15.
Single dose oral etoricoxib for acute postoperative pain in adults.
Clarke R, Derry S, Moore RA, McQuay HJ.
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004309. Review.
Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
van der Heijde D, Baraf HS, Ramos-Remus C, Calin A, Weaver AL, Schiff M, James M, Markind JE, Reicin AS, Melian A, Dougados M.
Arthritis Rheum. 2005 Apr;52(4):1205-15.
Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.
Cannon CP, Curtis SP, Bolognese JA, Laine L; MEDAL Steering Committee.
Am Heart J. 2006 Aug;152(2):237-45.
Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports.
Moore RA, Derry S, McQuay HJ.
Arthritis Res Ther. 2008;10(3):R53. Epub 2008 May 8.
Evaluation of quality of life following treatment with etoricoxib in patients with arthritis or low-back pain: an open label, uncontrolled pilot study in Mexico.
Ramos-Remus CR, Hunsche E, Mavros P, Querol J, Suarez R.
Curr Med Res Opin. 2004 May;20(5):691-8.
Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial.
Pallay RM, Seger W, Adler JL, Ettlinger RE, Quaidoo EA, Lipetz R, O'Brien K, Mucciola L, Skalky CS, Petruschke RA, Bohidar NR, Geba GP.
Scand J Rheumatol. 2004;33(4):257-66.
Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo.
Bingham CO 3rd, Smugar SS, Wang H, Tershakovec AM.
Rheumatology (Oxford). 2009 Sep;48(9):1122-7. Epub 2009 Jul 9.
Lumiracoxib in the treatment of osteoarthritis, rheumatoid arthritis and acute postoperative dental pain: results of three dose-response studies.
Schnitzer TJ, Gitton X, Jayawardene S, Sloan VS.
Curr Med Res Opin. 2005 Jan;21(1):151-61.
Efficacy of etoricoxib for pain relief during endometrial biopsy; a double blind randomized controlled trial.
Tanprasertkul C, Pongrojpow D.
J Med Assoc Thai. 2008 Jan;91(1):13-8.
Etoricoxib for pain management during thyroid surgery--a prospective, placebo-controlled study.
Smirnov G, Terävä M, Tuomilehto H, Hujala K, Seppänen M, Kokki H.
Otolaryngol Head Neck Surg. 2008 Jan;138(1):92-7.
Oral etoricoxib for pain relief during fractional curettage: a randomized controlled trial.
Phittayawechwiwat W, Thanantaseth C, Ayudhya NI, O-Prasertsawat P, Kongprasert J.
J Med Assoc Thai. 2007 Jun;90(6):1053-7.
Efficacy and safety of piroxicam patch versus piroxicam cream in patients with lumbar osteoarthritis. A randomized, placebo-controlled study.
Allegrini A, Nuzzo L, Pavone D, Tavella-Scaringi A, Giangreco D, Bucci M, Toniato E, Mezzetti A, Martinotti S, Comuzio S, Di Grigoli M, Bonani S.
Arzneimittelforschung. 2009;59(8):403-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on